University of Miami
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Miami sits in the top decile of US sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count).
University of Miami: 721 sponsored US clinical trials, 145 recruiting.
University of Miami sponsors 721 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 430 completed. 79 of these trials are in Phase 3-4 (later-stage) and 134 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 10 trials.
Top-decile sponsor footprint
University of Miami ranks in the top decile of sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
430 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
721 total, page 2 of 15
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
NCT05958017
Neural and Psychiatric Consequences of Cannabis Use in Adolescents
NCT06941298
Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT
NCT06807866
Bikini vs Longitudinal Incision in Direct Anterior Approach (DAA) Total Hip Arthroplasty (THA)
NCT06831045
Efficacy Trial of Healthy Together ("Juntos")
NCT06489262
Botox for Chronic Pelvic Pain
NCT06796985
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
NCT06627244
Aviclear for Hidradenitis Suppurativa (HS)
NCT06801795
Auricular Vagus Nerve Stimulation (aVNS) in Chronic Spinal Cord Injuries (SCI)
NCT06588608
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
NCT05745285
General vs Spinal in Total Joint Arthroplasty (TJA)
NCT06747494
Addressing Food Insecurity: Plant-Based Food Prescription Program
NCT06614920
Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
NCT06578156
Radiotherapy Patient Education With Virtual Reality
NCT06506435
Finishing HIV Project
NCT06406049
Joining Under-connected Networks to Optimize "Salud" (Health) ("JUNTOS")
NCT06432725
The University of Miami Adapt (UAdapt) Trial
NCT06111313
A Novel Repetitive Synchronized Associative Stimulation Neuromodulation Approach for Spinal Cord Injury Patients
NCT06494059
Rosacea Radiofrequency Microneedling
NCT06801717
Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)
NCT06672458
Dyadic Sleep Study
NCT06569693
Comprehensive HIV and Harm Prevention Via Telehealth
NCT05897099
Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)
NCT06293300
Precise Oncology Interventions in Nutrition and Training (OnPoint)
NCT06534918
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
NCT06123988
Assessment of Neural Signals for the Control of Assistive Devices
NCT06533969
Task Practice and Spinal Cord Stimulation
NCT06494020
Striving Towards EmPowerment and Medication Adherence R01
NCT06463886
FAMILY Sleep Program
NCT06571305
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
NCT06261346
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
NCT06392295
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
NCT06494033
Brain-Controlled Spinal Stimulation Walking Therapy After Incomplete Spinal Cord Injury (SCI)
NCT06406855
Targeted Navigation in Hepatocellular Carcinoma (HCC)
NCT06260943
PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
NCT06124508
Smoking Cessation Program in the Construction Sector
NCT06098144
Non-standardized vs. Standardized Screening for Dysphagia
NCT05603897
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
NCT06089161
Families With Pride ("Familias Con Orgullo").
NCT06057337
Spinal Cord Injury Model Systems (SCIMS) - Education Module
NCT06003686
Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
NCT06062342
Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)
NCT05903859
The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE
NCT05974488
Geolocation Positional System (GPS) Experience
NCT05991713
Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
NCT04669886
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
NCT05366816
Utility of Multisensory Body-Representation in Spinal Cord Injury (SCI) With Pain
NCT06010251
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
NCT05777031
Community Health Advocates for Motivating PAP Use in Our Neighborhoods.
NCT06047353
Unified Protocol: Community Connections
NCT06038721
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 86 |
| Phase 3 | 18 |
| Phase 4 | 61 |
Therapeutic Areas
What is open in the University of Miami pipeline
145 recruiting of 721 indexed (20% open); 430 completed (60%).
Phase mix: 79 late (III/IV) vs 134 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Miami: open-pipeline peers nationwide
Peers matched on 721 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 721 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of California, Irvine · 20% recruiting · 368 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of Miami page
721 registered trials is a research-attention snapshot, not an endorsement of University of Miami or any single study.
- 145 of University of Miami's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Miami studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Miami pipeline card: 721 registered trials from official public datasets.Report a data error.